Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: AJNR Am J Neuroradiol. 2019 Jun 27;40(7):1132–1139. doi: 10.3174/ajnr.A6110

Figure 3.

Figure 3.

Kaplan-Meier curves for 2D-T1 and dT1-determined enhancing tumor. Shown are overall survival curves stratified by whether the participant (a) progressed at or prior to week 8 (b) progressed at or prior to week 8, broken into progressing (P) responding (R) and non-responding/non-progressing (NR-NP), (c) progressed at or prior to week 16 and (d) had progressed at or prior to week 16, broken into P, R and NR-NP.